| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |